Pharmaceutical Lobby
The pharmaceutical industry is one of the most powerful lobbying forces in Washington, spending more than any other sector to influence healthcare legislation. Big Pharma directs contributions to members of Congress on health-related committees to block drug pricing reform, extend patent monopolies, and shape FDA regulatory policy in ways that protect profit margins over public health.
Party Breakdown
Top 10 Recipients
No tracked funding data available for this industry yet.
Frequently Asked Questions
How much does Big Pharma spend on lobbying Congress?
The pharmaceutical and health products industry is the top-spending lobbying sector in the United States, investing over $350 million annually. This exceeds spending by insurance, oil, tech, and defense industries combined. The industry deploys more lobbyists than there are members of Congress.
Why does the U.S. pay the highest drug prices in the world?
U.S. drug prices are the highest globally in large part because pharmaceutical companies have successfully lobbied to block Medicare from negotiating drug prices (until limited provisions in the Inflation Reduction Act), extended patent protections through pay-for-delay agreements, and resisted importation of cheaper drugs from other countries. These lobbying efforts directly translate to higher consumer costs.
Which politicians receive the most from pharmaceutical companies?
Members of the Senate Finance Committee, Senate HELP Committee, House Energy and Commerce Committee, and House Ways and Means Committee — all of which oversee healthcare policy — receive the most pharmaceutical contributions. Both parties receive significant funding, though the distribution shifts based on which party controls relevant committees.